PTEN and urinary bladder carcinoma: Variation in PI3K is seen in various tumors with abnormal activation of the tumor suppressor PTEN [39], for example, in pancreatic cancer, colon cancer, bladder cancer, cervical cancer, uterine endometrial cancer, ovarian cancer, and liver cancer that harbor Ras mutations [40].